-
August 13, 2026AVAC Statement on the National Vaccine Advisory Committee
AVAC is concerned about recent changes to the National Vaccine Advisory Committee (NVAC) charter that seek to expand its work beyond vaccines and immunization. With HHS now also soliciting nominations for new committee members, AVAC is urging the department to keep NVAC focused on its core mission of vaccines and immunization. For decades, NVAC has […]
Letters to Administration
July 14, 2026AVAC Statement on Pending Public Health Leadership Nominations in the United States Senate
AVAC issued a statement ahead of the Senate hearing on nominees to lead the Centers for Disease Control and Prevention (CDC) and the Administration for Strategic Preparedness and Response (ASPR). Read the full statement.
Letters to Administration
May 26, 2026AVAC Comments to FDA on Vaccine and Related Biological Product Advisory Committee May Meeting
AVAC comments provided to the Food and Drug Administration (FDA) in advance of the Vaccine and Related Biological Product Advisory Committee (VRBPAC) meeting on May 28, 2026. Read the full letter.
Letters to Administration
April 14, 2026AVAC Statement Ahead of HHS Secretary Kennedy’s Congressional Hearings on the Fiscal Year 2027 Budget
AVAC issued a statement ahead of HHS Secretary Kennedy’s FY2027 budget hearings, highlighting the importance of protecting Americans’ access to vaccines. Read the full statement.
Letters to Administration
March 13, 2026AVAC Comments to CMS on Patient Protection and Affordable Care Act; and more
AVAC comments to the Centers of Medicare & Medicaid Services (CMS) on the Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program. Read the full letter.
Letters to Administration
March 11, 2026AVAC Comments to FDA on Vaccine and Related Biological Product Advisory Committee Meeting
AVAC comments provided to the Food and Drug Administration (FDA) in advance of the Vaccine and Related Biological Product Advisory Committee (VRBPAC) meeting on March 12, 2026. Read the full letter.
Letters to Administration
January 28, 2025AVAC Comments on Contract Year 2026 Proposed Medicare & Medicaid Rule
On January 27, 2025, AVAC submitted comments on the proposed rule, “Medicare and Medicaid Programs: Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly.” Specifically: Support codifying that any ACIP-recommended adult vaccine is exempted from […]
Letters to Administration Strengthening Vaccine Access
September 29, 2022AVAC Memo RE: CMS-1770-P Medicare Program: CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements etc.
FROM: The Adult Vaccine Access Coalition (AVAC) TO: Centers for Medicare & Medicaid Services Attention: CMS-1770-P DATE: September 6, 2022 RE: CMS-1770-P Medicare Program: CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements etc. The Adult Vaccine Access Coalition (AVAC) appreciates the […]
Letters to Administration Supporting Providers
April 18, 2022AVAC Letter to OIDP Vaccines Federal Implementation Plan Public Comment
March 29, 2022 David Kim, M.D. Office of Infectious Disease and HIV/AIDS Policy Department of Health and Human Services 200 Independence Ave. SW Washington, DC 20201 RE: Vaccines Federal Implementation Plan Public Comment Dear Dr. Kim: As participants in the Adult Vaccine Access Coalition (AVAC), we appreciate the opportunity to comment on the Office of […]
Letters to Administration Benefits of Immunization
March 4, 2022AVAC Comments on Medicare Advantage and Part D Advance Notice and Draft Call Letter
AVAC comments on the Centers for Medicare and Medicaid Services (CMS) 2022 Medicare Advantage and Part D Advance Notice and Draft Call Letter. Read the full letter.
Letters to Administration
February 8, 2022AVAC Comments on Healthy People 2030
January 10, 2022 Carter Blakey Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services 1101 Wootton Parkway, Suite 420, Rockville, MD 20852 Dear Director Blakey, Members of the Adult Vaccine Access Coalition (AVAC) and stakeholder partners, we appreciate the opportunity to offer comments on Healthy People 2030 and make recommendations […]
Letters to Administration Benefits of Immunization
September 20, 2021AVAC Submits Comments on the Hospital Outpatient Prospective Payment
To Whom It May Concern: As participants in the Adult Vaccine Access Coalition (AVAC), we appreciate the opportunity to comment on Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; etc. Specifically, AVAC wishes to highlight its strong support for the following proposals included in this proposed rulemaking: […]
Letters to Administration Reducing Financial Barriers